Published in PLoS One on September 28, 2012
Improving access to psychological therapies and older people: findings from the Eastern Region. Behav Res Ther (2014) 0.88
Embedding telephone therapy in statutory mental health services: a qualitative, theory-driven analysis. BMC Psychiatry (2016) 0.77
Effects of armodafinil and cognitive behavior therapy for insomnia on sleep continuity and daytime sleepiness in cancer survivors. Sleep Med (2015) 0.76
Study protocol for a randomized controlled trial of telephone-delivered cognitive behavior therapy compared with befriending for treating depression and anxiety in older adults with COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Telephone-administered versus live group cognitive behavioral stress management for adults with CFS. J Psychosom Res (2016) 0.75
Is duration of psychological treatment for depression related to return into treatment? Soc Psychiatry Psychiatr Epidemiol (2016) 0.75
The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord (2016) 0.75
Feasibility and utility of telephone-based psychological support for people with brain tumor: a single-case experimental study. Front Oncol (2015) 0.75
A Hybrid Web-Based and In-Person Self-Management Intervention to Prevent Acute to Chronic Pain Transition After Major Lower Extremity Trauma (iPACT-E-Trauma): Protocol for a Pilot Single-Blind Randomized Controlled Trial. JMIR Res Protoc (2017) 0.75
A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med (2006) 21.56
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52
The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry (2002) 6.02
Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord (2004) 4.66
The case for psychological treatment centres. BMJ (2006) 4.46
Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research. Psychol Bull (1990) 2.03
The Effect of Telephone-Administered Psychotherapy on Symptoms of Depression and Attrition: A Meta-Analysis. Clin Psychol (New York) (2008) 2.02
Improving access to psychological therapies: phase IV prospective cohort study. Br J Clin Psychol (2009) 2.00
Barriers to psychotherapy among depressed and nondepressed primary care patients. Ann Behav Med (2006) 1.85
Psychotherapy mediated by remote communication technologies: a meta-analytic review. BMC Psychiatry (2008) 1.53
Effectiveness of cognitive-behavioural, person-centred, and psychodynamic therapies in UK primary-care routine practice: replication in a larger sample. Psychol Med (2007) 1.33
Defining successful treatment outcome in depression using the PHQ-9: a comparison of methods. J Affect Disord (2010) 1.23
Telephone administered cognitive behaviour therapy for treatment of obsessive compulsive disorder: randomised controlled non-inferiority trial. BMJ (2006) 1.14
Effectiveness of cognitive-behavioural, person-centred and psychodynamic therapies as practised in UK National Health Service settings. Psychol Med (2006) 1.04
Comparative effectiveness research: relative successes. JAMA (2012) 0.91
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84
Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03
Why psychiatry can't afford to be neurophobic. Br J Psychiatry (2009) 3.80
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ (2012) 2.70
Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort. BMJ (2009) 2.47
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. Br J Psychiatry (2012) 2.41
Disease-relevant autoantibodies in first episode schizophrenia. J Neurol (2010) 2.33
Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction (2007) 2.20
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Schizophrenia in the offspring of antenatally depressed mothers in the northern Finland 1966 birth cohort: relationship to family history of psychosis. Am J Psychiatry (2009) 2.11
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res (2011) 2.09
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry (2011) 2.06
Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch Gen Psychiatry (2008) 1.96
Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94
The Short Mood and Feelings Questionnaire (SMFQ): a unidimensional item response theory and categorical data factor analysis of self-report ratings from a community sample of 7-through 11-year-old children. J Abnorm Child Psychol (2006) 1.85
Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76
Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72
Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry (2007) 1.71
Infant developmental milestones and subsequent cognitive function. Ann Neurol (2007) 1.69
Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis. Am J Epidemiol (2003) 1.65
Childhood cognitive ability and adult mental health in the British 1946 birth cohort. Soc Sci Med (2007) 1.54
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum (2012) 1.54
Forty-year psychiatric outcomes following assessment for internalizing disorder in adolescence. Am J Psychiatry (2007) 1.54
Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53
Fear caused by intraoperative visual sensations during cataract surgery. Acta Ophthalmol Scand (2005) 1.47
A longitudinal typology of symptoms of depression and anxiety over the life course. Biol Psychiatry (2007) 1.47
Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr Res (2012) 1.46
Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry (2005) 1.42
Cannabis use and outcome of recent onset psychosis. Eur Psychiatry (2005) 1.42
Recovery from schizophrenic psychoses within the northern Finland 1966 Birth Cohort. J Clin Psychiatry (2005) 1.42
Neighbourhood-level effects on psychoses: re-examining the role of context. Psychol Med (2007) 1.38
Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project. Int J Epidemiol (2009) 1.37
Psychometric evaluation and predictive validity of Ryff's psychological well-being items in a UK birth cohort sample of women. Health Qual Life Outcomes (2006) 1.36
The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain (2003) 1.35
Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology (2005) 1.32
Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis (2010) 1.31
Gender differences in the association between childhood abuse and psychosis. Br J Psychiatry (2009) 1.30
Reproducibility of placebo analgesia: Effect of dispositional optimism. Pain (2009) 1.30
Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis. JAMA Psychiatry (2013) 1.25
Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci U S A (2002) 1.22
Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry (2007) 1.20
Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am J Psychiatry (2009) 1.20
Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging (2011) 1.19
Social deprivation, inequality, and the neighborhood-level incidence of psychotic syndromes in East London. Schizophr Bull (2012) 1.17
Visual experience during phacoemulsification under topical versus retrobulbar anesthesia: results of a prospective, randomized, controlled trial. Am J Ophthalmol (2004) 1.17
Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort. Soc Psychiatry Psychiatr Epidemiol (2003) 1.16
Profiles of family-focused adverse experiences through childhood and early adolescence: the ROOTS project a community investigation of adolescent mental health. BMC Psychiatry (2011) 1.15
Predictors of schizophrenia--a review. Br Med Bull (2005) 1.15
The placebo effect: advances from different methodological approaches. J Neurosci (2011) 1.13
Mokken scale analysis of mental health and well-being questionnaire item responses: a non-parametric IRT method in empirical research for applied health researchers. BMC Med Res Methodol (2012) 1.11
The pros and cons of early diagnosis in dementia. Br J Gen Pract (2013) 1.08
Visuospatial learning and executive function are independently impaired in first-episode psychosis. Psychol Med (2005) 1.08
Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia. Proc Natl Acad Sci U S A (2006) 1.08
The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther (2012) 1.08
Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res (2006) 1.07
Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms. Proc Natl Acad Sci U S A (2014) 1.07
Prevalence of depression in older people in England and Wales: the MRC CFA Study. Psychol Med (2007) 1.06
Acute and transient psychotic disorders: precursors, epidemiology, course and outcome. Br J Psychiatry (2004) 1.06
Classifying patients by antipsychotic adherence patterns using latent class analysis: characteristics of nonadherent groups in the California Medicaid (Medi-Cal) program. Value Health (2008) 1.06
The persistence of developmental markers in childhood and adolescence and risk for schizophrenic psychoses in adult life. A 34-year follow-up of the Northern Finland 1966 birth cohort. Schizophr Res (2004) 1.05
Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children. Am J Psychiatry (2009) 1.05
The prevention of schizophrenia--what can we learn from eco-epidemiology? Schizophr Bull (2010) 1.02
Incentive motivation in first-episode psychosis: a behavioural study. BMC Psychiatry (2008) 1.01
The acceptability of routine inquiry about domestic violence towards women: a survey in three healthcare settings. Br J Gen Pract (2006) 1.01
Quality of life in multiple sclerosis: translation in French Canadian of the MSQoL-54. Health Qual Life Outcomes (2003) 1.01
The structural brain correlates of neurological soft signs in healthy individuals. Cereb Cortex (2005) 1.00
Neighbourhood variation in the incidence of psychotic disorders in Southeast London. Soc Psychiatry Psychiatr Epidemiol (2007) 1.00
Improvements in social functioning reported by a birth cohort in mid-adult life: A person-centred analysis of GHQ-28 social dysfunction items using latent class analysis. Pers Individ Dif (2007) 1.00
Intrinsic curvature: a marker of millimeter-scale tangential cortico-cortical connectivity? Int J Neural Syst (2011) 1.00
Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness. Schizophr Bull (2008) 0.99
Expressed emotion: relevance to rehospitalization in schizophrenia over 7 years. Schizophr Bull (2005) 0.99
Association of cannabis use with prodromal symptoms of psychosis in adolescence. Br J Psychiatry (2008) 0.99
Cohort profile: mental health following extreme trauma in a northern Ugandan cohort of War-Affected Youth Study (The WAYS Study). Springerplus (2013) 0.97
Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics. Early Interv Psychiatry (2011) 0.95
Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. Arthritis Res Ther (2010) 0.95
Placebo analgesia as a case of a cognitive style driven by prior expectation. Brain Res (2010) 0.95
Early risk factors for suicide in an epidemiological first episode psychosis cohort. Schizophr Res (2010) 0.94
A population-level prediction tool for the incidence of first-episode psychosis: translational epidemiology based on cross-sectional data. BMJ Open (2013) 0.93
Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study. Am J Psychiatry (2011) 0.93
Psychotic symptoms in young people without psychotic illness: mechanisms and meaning. Br J Psychiatry (2012) 0.92
Neurological abnormalities and cognitive ability in first-episode psychosis. Br J Psychiatry (2008) 0.92
Incidence of bipolar affective disorder in three UK cities: results from the AESOP study. Br J Psychiatry (2005) 0.92
Hippocampus and amygdala volumes in schizophrenia and other psychoses in the Northern Finland 1966 birth cohort. Schizophr Res (2004) 0.91
Ethnic identity, perceptions of disadvantage, and psychosis: findings from the ÆSOP study. Schizophr Res (2010) 0.91
Familial expressed emotion: outcome and course of Israeli patients with schizophrenia. Schizophr Bull (2002) 0.91
The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression. Neuropsychopharmacology (2005) 0.90
Reassessing the long-term risk of suicide after a first episode of psychosis. Arch Gen Psychiatry (2010) 0.90
Duration of untreated psychosis and neuropsychological function in first episode psychosis. Schizophr Res (2007) 0.90